About the Company
synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
5
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $SNPX News
Synaptogenix, Inc. (SNPX) Stock Historical Prices & Data - Yahoo Finance
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Synaptogenix Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Synaptogenix Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Synaptogenix, Inc. Common Stock (SNPX)
Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC ...
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.18%
Greenbrook TMS Inc (NASDAQ:GBNH) which lost 46.69% to settle at 0.20 and Synaptogenix Inc (NASDAQ:SNPX) which was down 29.45% to 0.19 at the close. Rising stocks outnumbered declining ones on the ...
Synaptogenix (SNPX) Receives a Buy from Maxim Group
In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Synaptogenix (SNPX – Research Report), with a price target of $14.00. The company's shares closed last ...
Sweet Baby Inc. Doesn’t Do What Some Gamers Think It Does
Sweet Baby Inc. is not the largest narrative design company in the games industry. Nor is it solely responsible for the characters and stories in recent high-profile releases like Alan Wake 2 ...
Synaptogenix, Inc. (SNPX)
Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that its President ...
Synaptogenix, Inc. (SNPX) stock historical prices & data – Yahoo Finance
*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.18%
Greenbrook TMS Inc (NASDAQ:GBNH) which lost 46.69% to settle at 0.20 and Synaptogenix Inc (NASDAQ:SNPX) which was down 29.45% to 0.19 at the close. Advancing stocks outnumbered falling ones by ...
Loading the latest forecasts...